Bellus Health Inc
BLU·Stocks·Biotechnology·Canada·Nasdaq·USD | CAD
Price
$3.35
Today
+0.0%
YTD
+0.0%
About
Based in Laval, Canada and working internationally, Bellus Health is a healthcare company. It was launched in 1993 and creates drug candidates to treat problems such as chronic coughs. It trades with the ticker BLU on the NASDAQ GS. If you’d like BLU price chart information, find all the information you need on eToro.
Price chart
Closing price history for BLU (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)-20.45
P/S (TTM)124387.50
P/B (TTM)5.06
Market cap$1.87B
Cap tierSmall-cap
Industry avg P/E-2.18
Profitability
Gross marginUnknown
EBIT margin-604966.67%
Net margin-835333.33%
ROE-26.76%
ROA-25.68%
Earnings & Revenue
Revenue (TTM)$15,000.00
Revenue growth (1Y)-6.3%
EPS (TTM)-$0.72
Free cash flow$-83.14M
Total debt$1.20M
Dividends & Risk
Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)0.46
Employees74
Next earnings9 Aug '23
Trade history
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.